1. Home
  2. CGAU vs ENOV Comparison

CGAU vs ENOV Comparison

Compare CGAU & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGAU
  • ENOV
  • Stock Information
  • Founded
  • CGAU 2002
  • ENOV 1995
  • Country
  • CGAU Canada
  • ENOV United States
  • Employees
  • CGAU N/A
  • ENOV N/A
  • Industry
  • CGAU Precious Metals
  • ENOV Fluid Controls
  • Sector
  • CGAU Basic Materials
  • ENOV Industrials
  • Exchange
  • CGAU Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • CGAU 1.5B
  • ENOV 1.6B
  • IPO Year
  • CGAU N/A
  • ENOV 2008
  • Fundamental
  • Price
  • CGAU $7.29
  • ENOV $26.43
  • Analyst Decision
  • CGAU Buy
  • ENOV Strong Buy
  • Analyst Count
  • CGAU 2
  • ENOV 5
  • Target Price
  • CGAU $13.00
  • ENOV $55.60
  • AVG Volume (30 Days)
  • CGAU 837.6K
  • ENOV 1.5M
  • Earning Date
  • CGAU 08-06-2025
  • ENOV 08-07-2025
  • Dividend Yield
  • CGAU 2.76%
  • ENOV N/A
  • EPS Growth
  • CGAU N/A
  • ENOV N/A
  • EPS
  • CGAU 0.18
  • ENOV N/A
  • Revenue
  • CGAU $1,208,123,000.00
  • ENOV $2,150,191,000.00
  • Revenue This Year
  • CGAU $3.17
  • ENOV $8.23
  • Revenue Next Year
  • CGAU $7.82
  • ENOV $6.18
  • P/E Ratio
  • CGAU $39.38
  • ENOV N/A
  • Revenue Growth
  • CGAU 2.88
  • ENOV 18.32
  • 52 Week Low
  • CGAU $5.41
  • ENOV $25.47
  • 52 Week High
  • CGAU $7.82
  • ENOV $49.83
  • Technical
  • Relative Strength Index (RSI)
  • CGAU 52.84
  • ENOV 36.08
  • Support Level
  • CGAU $6.78
  • ENOV $25.47
  • Resistance Level
  • CGAU $7.70
  • ENOV $27.79
  • Average True Range (ATR)
  • CGAU 0.21
  • ENOV 1.25
  • MACD
  • CGAU -0.02
  • ENOV -0.13
  • Stochastic Oscillator
  • CGAU 55.43
  • ENOV 16.24

About CGAU Centerra Gold Inc.

Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: